Skip to main content
. 2020 Feb 25;95(14):e2028–e2037. doi: 10.1212/WNL.0000000000009183

Figure 1. Flowchart of patient selection.

Figure 1

Double line indicates cohorts selected for comparison of anti-PrPC autoantibody titers from individuals carrying wild-type or mutated PRNP alleles (right of double line) and cohort selected for comparing anti-PrPC autoantibody titers of symptomatic vs asymptomatic mutation carriers (left of double line). Blue boxes indicate matched cohorts.